User menu

Accès à distance ? S'identifier sur le proxy UCLouvain | Saint-Louis

Effectiveness and Toxicity of Cisplatin and Doxorubicin (plado) in Childhood Hepatoblastoma and Hepatocellular-carcinoma - a Siop Pilot-study

  1. Quinn, Cancer, 56, 1926 (1985)
  2. Shafford, Med Pediatr Oncol, 16, 417 (1988)
  3. Ackland, Clin Pharmacol Ther, 45, 340 (1989)
  4. LEGHA SEWA S., Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion, 10.7326/0003-4819-96-2-133
  5. Reddel, Cancer Treat Rep, 67, 169 (1983)
  6. Kelsen, Am J Clin Oncol, 8, 77 (1985)
  7. Dominici, J Clin Oncol, 7, 100 (1989)
  8. Forestiere, Cancer Res, 48, 3869 (1988)
  9. Ritch, Proc AACR, 20, 61 (1979)
  10. Drewinko, Cancer Res, 33, 3091 (1973)
  11. WHO: “WHO Handbook for Reporting Results of Cancer Treatment.” WHO offset publication No. 48. Geneva: WHO, 1979.
  12. Ortega, Med Pediatr Oncol, 17, 277 (1989)
  13. Neglia, Cancer Treat Rep, 70, 655 (1986)
  14. Perilongo, Med Pediatr Oncol, 17, 179 (1989)
  15. Ablin, Med Pediatr Oncol, 16, 417 (1988)
Bibliographic reference Ninane, J. ; Otte, Jean-Bernard ; Perilongo, G. ; Stalens, JP. ; Guglielmi, M. ; et. al. Effectiveness and Toxicity of Cisplatin and Doxorubicin (plado) in Childhood Hepatoblastoma and Hepatocellular-carcinoma - a Siop Pilot-study. In: Medical and Pediatric Oncology, Vol. 19, no. 3, p. 199-203 (1991)
Permanent URL http://hdl.handle.net/2078.1/51147